This report provides a comprehensive analysis of the global companion animal cancer screening service market, detailing its projected growth through 2032. It examines various technologies, including liquid biopsy, genomic testing, and AI-driven cytology, used for early cancer detection in pets. The study covers the entire value chain, from upstream reagent suppliers to downstream veterinary clinics, while analyzing key market drivers and regional trends. Furthermore, it evaluates competitive landscapes and strategic maneuvers among major industry players.

Market Overview

The global Companion Animal Cancer Screening Service market size is predicted to grow from US$ 229 million in 2025 to US$ 380 million in 2032, representing an expected compound annual growth rate (CAGR) of 7.5% from 2026 to 2032.

Service Definition and Utility

Definition: Companion Animal Cancer Screening Service refers to cancer risk assessment and early screening services designed for companion animals, such as dogs and cats. These services typically utilize biological specimens—including blood, urine, cytology samples, or other materials—to detect various indicators such as tumor-related biomarkers, nucleosome signals, circulating cell-free DNA, genetic mutations, epigenetic features, or abnormal cellular morphology. This process assists in assessing potential cancer risks in pets.

Common Applications:

• Annual wellness checkups for senior pets
• Screening of high-risk breeds
• Adjunctive diagnosis for suspicious clinical signs
• Post-treatment recurrence monitoring

Clinical Role: While these services do not fully replace imaging, histopathology, or clinical diagnosis, they serve as an important front-end tool for early cancer detection and comprehensive pet health management.

Pricing Structure:

• Basic Screening: Blood- or urine-based tests are typically priced between USD 100–300 per test.
• Advanced Testing: Higher-end liquid biopsy, genomic, or epigenomic testing usually costs between USD 500–1,000 per test.

Supply Chain Analysis

Upstream (Suppliers and Inputs)

Includes antibodies, enzymes, primers and probes, sequencing reagents, sample collection tubes, preservation solutions, diagnostic kits, testing instruments, automated analysis platforms, AI pathology algorithms, and bioinformatics systems. Core reagents and analytical models are critical as they directly influence test sensitivity, specificity, and the interpretation of results.

Midstream (Service Providers)

Participants include veterinary diagnostic laboratories, pet molecular diagnostics companies, liquid biopsy developers, digital pathology platforms, and large pet healthcare groups. These entities are responsible for assay development, sample processing, laboratory testing, report generation, and clinical interpretation.

Downstream (Users and Delivery)

Users: Veterinary hospitals, clinics, veterinary oncology centers, pet wellness providers, breeding institutions, and premium pet health management customers. Delivery Models: Services are delivered through clinic-based sample submission, in-clinic testing, at-home sample collection, or specialized pet wellness packages.

Regional Market Insights

Global Trends

The report provides a comprehensive analysis of the global landscape, highlighting trends in product segmentation, company formation, revenue, market share, latest developments, and M&A activity. It also evaluates the strategies of leading global companies regarding their portfolios, capabilities, market entry strategies, market positions, and geographic footprints.

Regional Projections

• United States: The market is expected to experience significant growth through 2032.
• China: The market is projected to expand steadily over the forecast period.
• Europe: The market is anticipated to see continued growth through 2032.

Market Segmentation

By Type

• Blood Biomarker-Based Tumor Screening Services
• Liquid Biopsy and Genomic Testing Services
• Urine-Based or Volatile Metabolite Screening Services
• AI Cytology and Digital Pathology Screening Services

By Service Delivery Model

• In-Clinic Point-of-Care Testing
• Central Reference Laboratory Testing
• At-Home Sample Collection and Mail-In Testing
• Integrated Veterinary Oncology Screening Services

By Screening Purpose

• Annual Wellness Cancer Screening
• Adjunctive Diagnosis for Suspected Cancer
• Recurrence and Disease Monitoring
• High-Risk Breed Screening

By Application

• Pet Annual Wellness Checkups
• Initial Tumor Screening in Veterinary Clinics
• Post-Surgery and Post-Treatment Monitoring
• Premium Pet Healthcare and Insurance-Linked Screening

By Geography

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Key Players

The following companies have been profiled based on expert input and analysis of their market penetration and product portfolios:

• IDEXX Laboratories
• Zoetis Diagnostics
• Antech Diagnostics
• VolitionRx
• VDI Laboratory
• Oncotect
• CanCan Diagnostics
• Oxford BioDynamics
• FUJIFILM VET Systems
• Veterinary Pathology Group
• NationWide Laboratories
• BioGuard Corporation
• PETcision Biotech
• Uni-Pharma

Market Concentration

In 2025, the two largest companies in the global market are expected to hold a significant portion of the total market share.

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Companion Animal Cancer Screening Service Market Size (2021-2032)

    • 2.1.2 Companion Animal Cancer Screening Service Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for Companion Animal Cancer Screening Service by Country/Region (2021, 2025 & 2032)

  • 2.2 Companion Animal Cancer Screening Service Segment by Type

    • 2.2.1 Blood Biomarker-Based Tumor Screening Services

    • 2.2.2 Liquid Biopsy and Genomic Testing Services

    • 2.2.3 Urine-Based or Volatile Metabolite Screening Services

    • 2.2.4 AI Cytology and Digital Pathology Screening Services

    • 2.2.5 Companion Animal Cancer Screening Service Market Size by Type

      • 2.2.5.1 Companion Animal Cancer Screening Service Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.5.2 Global Companion Animal Cancer Screening Service Market Size Market Share by Type (2021-2026)

  • 2.3 Companion Animal Cancer Screening Service Segment by Service Delivery Model

    • 2.3.1 In-Clinic Point-of-Care Testing

    • 2.3.2 Central Reference Laboratory Testing

    • 2.3.3 At-Home Sample Collection and Mail-In Testing

    • 2.3.4 Integrated Veterinary Oncology Screening Services

    • 2.3.5 Companion Animal Cancer Screening Service Market Size by Service Delivery Model

      • 2.3.5.1 Companion Animal Cancer Screening Service Market Size CAGR by Service Delivery Model (2021 VS 2025 VS 2032)
      • 2.3.5.2 Global Companion Animal Cancer Screening Service Market Size Market Share by Service Delivery Model (2021-2026)

  • 2.4 Companion Animal Cancer Screening Service Segment by Screening Purpose

    • 2.4.1 Annual Wellness Cancer Screening

    • 2.4.2 Adjunctive Diagnosis for Suspected Cancer

    • 2.4.3 Recurrence and Disease Monitoring

    • 2.4.4 High-Risk Breed Screening

    • 2.4.5 Companion Animal Cancer Screening Service Market Size by Screening Purpose

      • 2.4.5.1 Companion Animal Cancer Screening Service Market Size CAGR by Screening Purpose (2021 VS 2025 VS 2032)
      • 2.4.5.2 Global Companion Animal Cancer Screening Service Market Size Market Share by Screening Purpose (2021-2026)

  • 2.5 Companion Animal Cancer Screening Service Segment by Application

    • 2.5.1 Pet Annual Wellness Checkups

    • 2.5.2 Initial Tumor Screening in Veterinary Clinics

    • 2.5.3 Post-Surgery and Post-Treatment Monitoring

    • 2.5.4 Premium Pet Healthcare and Insurance-Linked Screening

    • 2.5.5 Companion Animal Cancer Screening Service Market Size by Application

      • 2.5.5.1 Companion Animal Cancer Screening Service Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.5.5.2 Global Companion Animal Cancer Screening Service Market Size Market Share by Application (2021-2026)

• 3 Companion Animal Cancer Screening Service Market Size by Player

  • 3.1 Companion Animal Cancer Screening Service Market Size Market Share by Player

    • 3.1.1 Global Companion Animal Cancer Screening Service Revenue by Player (2021-2026)

    • 3.1.2 Global Companion Animal Cancer Screening Service Revenue Market Share by Player (2021-2026)

  • 3.2 Global Companion Animal Cancer Screening Service Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 Companion Animal Cancer Screening Service by Region

  • 4.1 Companion Animal Cancer Screening Service Market Size by Region (2021-2026)

  • 4.2 Global Companion Animal Cancer Screening Service Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Companion Animal Cancer Screening Service Market Size Growth (2021-2026)

  • 4.4 APAC Companion Animal Cancer Screening Service Market Size Growth (2021-2026)

  • 4.5 Europe Companion Animal Cancer Screening Service Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa Companion Animal Cancer Screening Service Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas Companion Animal Cancer Screening Service Market Size by Country (2021-2026)

  • 5.2 Americas Companion Animal Cancer Screening Service Market Size by Type (2021-2026)

  • 5.3 Americas Companion Animal Cancer Screening Service Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Companion Animal Cancer Screening Service Market Size by Region (2021-2026)

  • 6.2 APAC Companion Animal Cancer Screening Service Market Size by Type (2021-2026)

  • 6.3 APAC Companion Animal Cancer Screening Service Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe Companion Animal Cancer Screening Service Market Size by Country (2021-2026)

  • 7.2 Europe Companion Animal Cancer Screening Service Market Size by Type (2021-2026)

  • 7.3 Europe Companion Animal Cancer Screening Service Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Companion Animal Cancer Screening Service by Region (2021-2026)

  • 8.2 Middle East & Africa Companion Animal Cancer Screening Service Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa Companion Animal Cancer Screening Service Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global Companion Animal Cancer Screening Service Market Forecast

  • 10.1 Global Companion Animal Cancer Screening Service Forecast by Region (2027-2032)

    • 10.1.1 Global Companion Animal Cancer Screening Service Forecast by Region (2027-2032)

    • 10.1.2 Americas Companion Animal Cancer Screening Service Forecast

    • 10.1.3 APAC Companion Animal Cancer Screening Service Forecast

    • 10.1.4 Europe Companion Animal Cancer Screening Service Forecast

    • 10.1.5 Middle East & Africa Companion Animal Cancer Screening Service Forecast

  • 10.2 Americas Companion Animal Cancer Screening Service Forecast by Country (2027-2032)

    • 10.2.1 United States Market Companion Animal Cancer Screening Service Forecast

    • 10.2.2 Canada Market Companion Animal Cancer Screening Service Forecast

    • 10.2.3 Mexico Market Companion Animal Cancer Screening Service Forecast

    • 10.2.4 Brazil Market Companion Animal Cancer Screening Service Forecast

  • 10.3 APAC Companion Animal Cancer Screening Service Forecast by Region (2027-2032)

    • 10.3.1 China Companion Animal Cancer Screening Service Market Forecast

    • 10.3.2 Japan Market Companion Animal Cancer Screening Service Forecast

    • 10.3.3 Korea Market Companion Animal Cancer Screening Service Forecast

    • 10.3.4 Southeast Asia Market Companion Animal Cancer Screening Service Forecast

    • 10.3.5 India Market Companion Animal Cancer Screening Service Forecast

    • 10.3.6 Australia Market Companion Animal Cancer Screening Service Forecast

  • 10.4 Europe Companion Animal Cancer Screening Service Forecast by Country (2027-2032)

    • 10.4.1 Germany Market Companion Animal Cancer Screening Service Forecast

    • 10.4.2 France Market Companion Animal Cancer Screening Service Forecast

    • 10.4.3 UK Market Companion Animal Cancer Screening Service Forecast

    • 10.4.4 Italy Market Companion Animal Cancer Screening Service Forecast

    • 10.4.5 Russia Market Companion Animal Cancer Screening Service Forecast

  • 10.5 Middle East & Africa Companion Animal Cancer Screening Service Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market Companion Animal Cancer Screening Service Forecast

    • 10.5.2 South Africa Market Companion Animal Cancer Screening Service Forecast

    • 10.5.3 Israel Market Companion Animal Cancer Screening Service Forecast

    • 10.5.4 Turkey Market Companion Animal Cancer Screening Service Forecast

  • 10.6 Global Companion Animal Cancer Screening Service Forecast by Type (2027-2032)

  • 10.7 Global Companion Animal Cancer Screening Service Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market Companion Animal Cancer Screening Service Forecast

• 11 Key Players Analysis

  • 11.1 IDEXX Laboratories

    • 11.1.1 IDEXX Laboratories Company Information

    • 11.1.2 IDEXX Laboratories Companion Animal Cancer Screening Service Product Offered

    • 11.1.3 IDEXX Laboratories Companion Animal Cancer Screening Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 IDEXX Laboratories Main Business Overview

    • 11.1.5 IDEXX Laboratories Latest Developments

  • 11.2 Zoetis Diagnostics

    • 11.2.1 Zoetis Diagnostics Company Information

    • 11.2.2 Zoetis Diagnostics Companion Animal Cancer Screening Service Product Offered

    • 11.2.3 Zoetis Diagnostics Companion Animal Cancer Screening Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 Zoetis Diagnostics Main Business Overview

    • 11.2.5 Zoetis Diagnostics Latest Developments

  • 11.3 Antech Diagnostics

    • 11.3.1 Antech Diagnostics Company Information

    • 11.3.2 Antech Diagnostics Companion Animal Cancer Screening Service Product Offered

    • 11.3.3 Antech Diagnostics Companion Animal Cancer Screening Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 Antech Diagnostics Main Business Overview

    • 11.3.5 Antech Diagnostics Latest Developments

  • 11.4 VolitionRx

    • 11.4.1 VolitionRx Company Information

    • 11.4.2 VolitionRx Companion Animal Cancer Screening Service Product Offered

    • 11.4.3 VolitionRx Companion Animal Cancer Screening Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 VolitionRx Main Business Overview

    • 11.4.5 VolitionRx Latest Developments

  • 11.5 VDI Laboratory

    • 11.5.1 VDI Laboratory Company Information

    • 11.5.2 VDI Laboratory Companion Animal Cancer Screening Service Product Offered

    • 11.5.3 VDI Laboratory Companion Animal Cancer Screening Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 VDI Laboratory Main Business Overview

    • 11.5.5 VDI Laboratory Latest Developments

  • 11.6 Oncotect

    • 11.6.1 Oncotect Company Information

    • 11.6.2 Oncotect Companion Animal Cancer Screening Service Product Offered

    • 11.6.3 Oncotect Companion Animal Cancer Screening Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 Oncotect Main Business Overview

    • 11.6.5 Oncotect Latest Developments

  • 11.7 CanCan Diagnostics

    • 11.7.1 CanCan Diagnostics Company Information

    • 11.7.2 CanCan Diagnostics Companion Animal Cancer Screening Service Product Offered

    • 11.7.3 CanCan Diagnostics Companion Animal Cancer Screening Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 CanCan Diagnostics Main Business Overview

    • 11.7.5 CanCan Diagnostics Latest Developments

  • 11.8 Oxford BioDynamics

    • 11.8.1 Oxford BioDynamics Company Information

    • 11.8.2 Oxford BioDynamics Companion Animal Cancer Screening Service Product Offered

    • 11.8.3 Oxford BioDynamics Companion Animal Cancer Screening Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 Oxford BioDynamics Main Business Overview

    • 11.8.5 Oxford BioDynamics Latest Developments

  • 11.9 FUJIFILM VET Systems

    • 11.9.1 FUJIFILM VET Systems Company Information

    • 11.9.2 FUJIFILM VET Systems Companion Animal Cancer Screening Service Product Offered

    • 11.9.3 FUJIFILM VET Systems Companion Animal Cancer Screening Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.9.4 FUJIFILM VET Systems Main Business Overview

    • 11.9.5 FUJIFILM VET Systems Latest Developments

  • 11.10 Veterinary Pathology Group

    • 11.10.1 Veterinary Pathology Group Company Information

    • 11.10.2 Veterinary Pathology Group Companion Animal Cancer Screening Service Product Offered

    • 11.10.3 Veterinary Pathology Group Companion Animal Cancer Screening Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.10.4 Veterinary Pathology Group Main Business Overview

    • 11.10.5 Veterinary Pathology Group Latest Developments

  • 11.11 NationWide Laboratories

    • 11.11.1 NationWide Laboratories Company Information

    • 11.11.2 NationWide Laboratories Companion Animal Cancer Screening Service Product Offered

    • 11.11.3 NationWide Laboratories Companion Animal Cancer Screening Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.11.4 NationWide Laboratories Main Business Overview

    • 11.11.5 NationWide Laboratories Latest Developments

  • 11.12 BioGuard Corporation

    • 11.12.1 BioGuard Corporation Company Information

    • 11.12.2 BioGuard Corporation Companion Animal Cancer Screening Service Product Offered

    • 11.12.3 BioGuard Corporation Companion Animal Cancer Screening Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.12.4 BioGuard Corporation Main Business Overview

    • 11.12.5 BioGuard Corporation Latest Developments

  • 11.13 PETcision Biotech

    • 11.13.1 PETcision Biotech Company Information

    • 11.13.2 PETcision Biotech Companion Animal Cancer Screening Service Product Offered

    • 11.13.3 PETcision Biotech Companion Animal Cancer Screening Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.13.4 PETcision Biotech Main Business Overview

    • 11.13.5 PETcision Biotech Latest Developments

  • 11.14 Uni-Pharma

    • 11.14.1 Uni-Pharma Company Information

    • 11.14.2 Uni-Pharma Companion Animal Cancer Screening Service Product Offered

    • 11.14.3 Uni-Pharma Companion Animal Cancer Screening Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.14.4 Uni-Pharma Main Business Overview

    • 11.14.5 Uni-Pharma Latest Developments

• 12 Research Findings and Conclusion